VaxLiant Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 2

VaxLiant General Information

Description

Developer of adjuvants intended to deliver vaccine's desired immune response. The company offers a portfolio of innovative ready-to-use and fully customizable adjuvants and provides unparalleled flexibility to help deliver antigens competitively as well as innovative antigen-delivery systems and technical support, thereby providing its customers the flexibility they need to develop and commercialize safe, effective vaccines.

Contact Information

Ownership Status
Out of Business
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 421 West Industrial Drive
  • Lincoln, NE 68528
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Corporate Office
  • 421 West Industrial Drive
  • Lincoln, NE 68528
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VaxLiant Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VaxLiant‘s full profile, request access.

Request a free trial

VaxLiant Patents

VaxLiant Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2018510874-A Adjuvant compositions and related methods Active 24-Mar-2015
JP-2017537106-A Adjuvant compositions and related methods Active 26-Nov-2014

VaxLiant FAQs

  • When was VaxLiant founded?

    VaxLiant was founded in 2013.

  • Where is VaxLiant headquartered?

    VaxLiant is headquartered in Lincoln, NE.

  • What industry is VaxLiant in?

    VaxLiant’s primary industry is Pharmaceuticals.

  • Is VaxLiant a private or public company?

    VaxLiant is a Private company.

  • What is VaxLiant’s current revenue?

    The current revenue for VaxLiant is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »